American Healthcare REIT Inc. Common Stock (NYSE: AHR) Stock Analysis & Fundamentals

AHRAmerican Healthcare REIT Inc. Common Stock

NYSE · US · Real Estate · Equity Real Estate Investment Trusts (REITs) · americanhealthcarereit.com

—Mkt Cap: —P/E: —

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housi…

Industry Peers

Equity Real Estate Investment Trusts (REITs)

Screen all

CBSM

Societe Centrale des Bois et des Scieries de la Manche S.A.

$145.30MUSDP/E 10.5

ADAMO

Adamas Trust, Inc. 9.250% Senior Notes Due 2031

—

DHCNL

Diversified Healthcare Trust

—

CIMO

Chimera Investment Corporation 9.250% Senior Notes due 2029

—

SCCF

Sachem Capital Corp. 7.125% Notes due 2027

—

TPTS

Terra Property Trust Inc. 7.00% Senior Secured Notes due 2029

Generation Income Properties Inc Warrant

Ellington Credit Company 8.50% Notes due 2031

—

SCCD

Sachem Capital Corp. 6.00% Note

—

PMTW

PennyMac Mortgage Investment Trust 9.00% Senior Notes due 2030

Two Harbors Investments Corp 9.375% Senior Notes due 2030

—

RWTO

Redwood Trust Inc. 9.00% Senior Notes Due 2029

Sachem Capital Corp. 8.00% Notes due 2027

—

CIMP

Chimera Investment Corporation 8.875% Senior Notes due 2030

—

SCCE

Sachem Capital Corp. 6.00% Notes due 2027

—

ADAMI

Adamas Trust Inc. 9.125% Senior Notes Due 2029

—

Key Statistics

Company

Market Cap—

Enterprise Value13.61B $

Revenue (TTM)2.50B $

Gross Profit466.59M $

Net Income (TTM)69.81M $

Revenue/Share13.79 USD

Last Price—

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees121

CountryUS

SectorReal Estate

IndustryEquity Real Estate Investment Trusts (REITs)

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)56.33

PEG—

EV/EBITDA30.43

EV/Revenue5.44

P/S4.85

P/B2.94

EPS (TTM)0.68

EPS (Forward)0.99

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin20.64%

Oper. Margin6.83%

EBITDA Margin17.86%

Profit Margin3.09%

ROE2.10%

ROA1.29%

Growth

Revenue Growth24.70%

Earnings Growth157.50%

Cash Flow & Leverage

Operating CF294.44M $

CapEx (TTM)128.56M $

FCF Margin15.84%

FCF Yield—

Net Debt1.41B $

Net Debt/EBITDA3.15

Balance Sheet

Debt/Equity0.51

Current Ratio1.31

Quick Ratio1.06

Book Value/Sh18.98 USD

Cash/Share0.7240 USD

Dividends

Fwd Div Rate1.000 USD

Trail. Div Rate1.000 USD

Div. Yield1.81%

5Y Avg Yield—

Payout Ratio147.06%

Ex-Div DateJun 30, 2026

Pay DateJul 17, 2026

Analyst Consensus

Rating1.4 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)63.67 USD

Target Range55.00 USD – 74.00 USD

# Analysts15

Ownership

Shares Out.218.00M

Float216.56M

Insiders0.61%

Institutions99.87%

Short Interest

Short Ratio8.0d

Short % Float13.29%

Short % Out.11.49%

Shares Short22.14M

Short (prev mo.)19.71M

Technical

SMA 5053.21 USD

SMA 20050.20 USD

Beta0.77

S&P 52W Chg21.00%

Avg Vol (30d)—

Avg Vol (10d)3.65M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—